Showing results (361-370 of 686) with videos related to

Sort By:
Pageof 69
International Journal of Cancer|June 9, 1995
Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenograftsH J Broxterman, N Feller, C M Kuiper, et al.
British Journal of Cancer|November 1, 1993
Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cellsC H Versantvoort, G J Schuurhuis, H M Pinedo, et al.
British Journal of Cancer|March 1, 1994
A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2A C Ogilvie, J W Baars, A J Eerenberg, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomasR Abele, M Clavel, P Dodion, et al.
Leukemia|July 1, 1997
Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemiaH J Broxterman, J Lankelma, H M Pinedo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomasH M Verheul, K Hoekman, F Lupu, et al.
Biochemical and Biophysical Research Communications|February 5, 2003
Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cellsM de Bruin, K Smid, A C Laan, et al.
European Journal of Internal Medicine|July 30, 2002
Treatment of haemangiopericytoma-associated hypoglycaemia with embolisationP W.B. Nanayakkara, J van Doorn, F G. van den Berg, et al.
Free Radical Research Communications|January 1, 1988
Semi-quinone formation from the catechol and ortho-quinone metabolites of the antitumor agent VP-16-213J M van Maanen, U H Verkerk, J Broersen, et al.
British Journal of Cancer|December 23, 1998
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenograftsP H Houba, E Boven, C A Erkelens, et al.
Pageof 69